Testing effectiveness (Phase 2)Study completedNCT04282980
What this trial is testing
DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)
Who this might be right for
Gastrointestinal Stromal Tumors
Zai Lab (Shanghai) Co., Ltd. 39